Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125434161 | 12543416 | 1 | I | 2014 | 20160129 | 20160711 | 20160711 | PER | US-TEVA-631353USA | TEVA | 0.00 | F | Y | 81.72000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125434161 | 12543416 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MILLIGRAM DAILY; TOOK LESS THAN 30 DAYS | Y | 76565 | 150 | MG | CAPSULE | QD | |||||
| 125434161 | 12543416 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 76565 | |||||||||||
| 125434161 | 12543416 | 3 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 76565 | |||||||||||
| 125434161 | 12543416 | 4 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 76565 | |||||||||||
| 125434161 | 12543416 | 5 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Y | 76565 | |||||||||||
| 125434161 | 12543416 | 6 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MILLIGRAM DAILY; | 0 | 150 | MG | CAPSULE | QD | ||||||
| 125434161 | 12543416 | 7 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125434161 | 12543416 | 8 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125434161 | 12543416 | 9 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125434161 | 12543416 | 1 | Depression |
| 125434161 | 12543416 | 2 | Hormone level abnormal |
| 125434161 | 12543416 | 3 | Premature menopause |
| 125434161 | 12543416 | 4 | Fatigue |
| 125434161 | 12543416 | 5 | Anxiety |
| 125434161 | 12543416 | 6 | Depression |
| 125434161 | 12543416 | 7 | Hormone level abnormal |
| 125434161 | 12543416 | 8 | Premature menopause |
| 125434161 | 12543416 | 9 | Vitamin supplementation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125434161 | 12543416 | Disturbance in attention | |
| 125434161 | 12543416 | Dizziness | |
| 125434161 | 12543416 | Drug dose omission | |
| 125434161 | 12543416 | Drug ineffective | |
| 125434161 | 12543416 | Emotional disorder | |
| 125434161 | 12543416 | Feeling abnormal | |
| 125434161 | 12543416 | Product quality issue | |
| 125434161 | 12543416 | Product substitution issue | |
| 125434161 | 12543416 | Product use issue | |
| 125434161 | 12543416 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125434161 | 12543416 | 1 | 201412 | 0 | ||
| 125434161 | 12543416 | 6 | 201501 | 0 |